[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100484418":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":18,"centralContacts":22,"locations":32,"responsibleParty":49,"collaborators":10,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Helse Stavanger HF","OTHER_GOV",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"Mild Cancer Related Fatigue",null,"After treatment(6 months from inclusion) is ended a fVAS \\\u003C 50",{"label":13,"type":10,"description":14,"interventionNames":10},"Cancer related Fatigue","After treatment (6 months from inclusion) with fVAS ≥ 50 mm or a rise of fVAS of ≥ 25 mm.",{"label":16,"type":10,"description":17,"interventionNames":10},"Healthy control","Healthy women matches with age\n\n1. 50-70: women attending the mammography screening\n2. 19-50: invitation in newspaper, flyers and posters",[19],{"name":20,"affiliation":5,"role":21},"Svein Skeie, PhD","STUDY_DIRECTOR",[23,28],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Tone Hoel Lende, PhD","CONTACT","47861295","leth@SUS.no",{"name":29,"role":25,"phone":30,"phoneExt":10,"email":31},"Håvard Søiland, PhD","45636028","hsoiland@gmail.com",[33],{"facility":5,"status":34,"city":35,"state":10,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","Stavanger","4068","Norway","NO",{"type":40,"coordinates":41},"Point",[42,43],5.73332,58.97005,{"lat":43,"lon":42},[46,48],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":47},"leth@sus.no",{"name":29,"role":25,"phone":30,"phoneExt":10,"email":31},{"type":50,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100484418","monitoring-of-chronic-conditions-in-breast-cancer-100484418",false,"NCT05587777","Monitoring of Chronic Conditions in Breast Cancer","REsearch on BrEast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data","REBECCA-1","Inclusion Criteria:\n\n* Breast cancer patients with histologically detectable M0 breast cancer (stage 0-III) who require neoadjuvant or adjuvant endocrine, chemo and \u002F or radiation therapy at least and no more than 3 months before initiation of study.\n* Female breast cancer patients between 19 and 80 years of age.\n* Patients who have increased their life expectancy beyond the first 3 months after starting treatment.\n* Patients who have the ability to understand the protocol and can participate in the follow-up plan.\n* Patients who have an absence of psychological, familial, sociological or geographical condition that potentially impedes compliance with the study protocol and follow-up plan.\n\nExclusion criteria:\n\n* Male breast cancer patients.\n* Patients who do not agree to the study protocol.\n* Patients with a previous cancer diagnosis (excluding skin cancer treated only by surgery).\n* Patients who have previously been treated with some form of chemotherapy \u002F radiation therapy.",true,"FEMALE","19 Years","80 Years",{"count":64,"type":65},150,"ESTIMATED","OBSERVATIONAL","REBECCA-1 is an observational study. Clinical research is undergoing a revolutionary change. The use of electronic patient records (EHR), digital registers, smartphones etc will create \"real-world data\" (RWD) that provides great opportunities for advancing clinical research, but so far this opportunity has been little exploited. The REBECCA -1 study will observe and monitor fatigue in breast cancer survivors. Investigators will use self reported questionnaires (PROM-data), blood tests and objective regulations like the REBECCCA -1 smart watch that will register amount of steps every day, leaving the house, visiting friends, cafes etc. There will be three observational arms; 1.high fatigue, 2. low fatigue and 3. a healthy control arm. After the patients have finished their treatment, they will receive the REBECCA smart watch, a REBECCA app on the smart phone and a REBECCA plus device on their computer, The next offend are also invited to report their evaluation through the same apps. The observational time will be 1 year and comparison between the subjective PROM data , the objective REBECCA watch and the biological samples will be obtained.",[69,70],"Breast Cancer","Chronic Fatigue Syndrome",[72,73],"fatigue","breast cancer","2022-10-19",{"date":76,"type":77},"2022-10-20","ACTUAL",{"date":79,"type":77},"2022-06-15",{"date":81,"type":65},"2028-06-15",{"name":5,"class":6},1]